StockWatch
·
Pharmaceuticals
Corporate Governance23 Sept 2026, 04:26 pm

Vivimed Labs Closes Trading Window for Q2/H1 FY27 Results

AI Summary

Vivimed Labs Limited has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter and half-year ended September 30, 2026. The specific date for the board meeting to approve these results will be communicated later. This measure is in compliance with SEBI regulations and the company's insider trading code.

Key Highlights

  • Trading window closed from October 1, 2026.
  • Closure is until 48 hours post Q2/H1 FY27 results declaration.
  • Aims to prevent insider trading during financial reporting.
  • Board meeting date for results to be announced separately.